Medtech Associations Regulatory Networking, July 2017 – Singapore, the Philippines, Myanmar
Executive Summary
The first Medtech Associations Regulatory Networking discussion, hosted by Medtech Insight and sponsored by the ARQon consultancy (Singapore) and the Asia Regulatory Professionals Association (ARPA), was held in mid-July. Updates were received from senior regulatory figures in three Asian medtech markets where regulation is evolving fast – Singapore, the Philippines and Myanmar.
You may also be interested in...
Singapore’s Priority-Review Scheme Goes Live
Only marketing applications submitted on or after Aug. 22 will be considered for Singapore’s new priority-review scheme for medical devices.
Singapore To Make Major Medtech Regulatory Changes Under Economic Growth Plan
Regulatory and market access improvements for medtech products were on the agenda at last month's Health Products Regulatory Forum in Singapore. These forward-looking changes are seen by the government and the Health Sciences Authority (HSA) as the medtech sector's contribution to initiatives and aims developed by the Singapore Committee on the Future Economy (CFE).
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.